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SUMMARY – Th e aim of this prospective study was to detect primary open angle glaucoma 
(POAG) in its early stage in patients at a higher risk of its development, and to identify the risk group 
with the highest prevalence of POAG. Th e study was conducted at Department of Ophthalmology, 
Osijek University Hospital Centre, and included 250 patients divided into fi ve groups, as follows: 
group 1, patients with diabetes type 1 and type 2; group 2, patients with arterial hypertension (blood 
pressure >140/90 mm Hg); group 3, patients with positive family history of POAG; group 4, patients 
with myopia between -3.0 and -8.0 diopters; and group 5, control group including patients aged 40 
with no risk factors for POAG development. Study results showed that distribution of glaucoma pa-
tients was not equal across the groups. Th e prevalence of POAG in all patients was 5.6%, whereas in 
patients with positive family history of POAG it was 14%, which was statistically signifi cantly higher 
than in patients with diabetes and myopia (4% both), as well as in control group. Th e diff erence was 
greatest in comparison to control group. Th ere was no statistically signifi cant diff erence in glaucoma 
incidence between the group of patients with positive family history (14%) and patients with sys-
temic hypertension (6%). Th e results obtained suggest that of all risk factors analyzed, positive family 
history of POAG is the most important risk factor for glaucoma development in all risk groups.
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Introduction
Glaucoma is the second leading cause of blindness 
worldwide. Primary open angle glaucoma (POAG) af-
fects about 2% of the world population aged 40 and 
older, only half of them being aware of having the dis-
ease and even less receiving appropriate therapy. It is 
therefore not surprising that there are about 7 million 
people blind on both eyes as the result of glaucoma1,2. 
Early detection of POAG and appropriate therapy can 
slow down the progression and sometimes arrest de-
velopment of the disease. Th us, it is of utmost impor-
tance to defi ne the risk factors contributing to disease 
development.
Th e best-known risk factor for glaucomatous optic 
neuropathy (GON) is increase in the intraocular pres-
sure (IOP). Apart from increased IOP, other possible 
risk factors are old age, family history of glaucoma, 
diabetes, cardiovascular diseases, systemic hyperten-
sion and hypotension, vasospastic syndromes3-5 and 
myopia (especially myopia of 6.0 or more diopters)6,7.
Taking into account the high incidence of primary 
glaucoma within families, it has been determined that 
the risk of glaucoma development is 3 to 6 times high-
er in fi rst-degree relatives than in the general popula-
tion. Up to the present, 17 genes have been identifi ed 
that can play a signifi cant role in glaucoma pathogen-
esis. Th e gene for POAG has been identifi ed on chro-
mosome 1q, where the Trabecular meshwork Induced 
Glucocorticoid Response protein (TIGR) gene is also 
J. Barać et al. Prevalence of POAG in risk groups
790 Acta Clin Croat, Vol. 56, No. 4, 2017
mapped. TIGR gene mutation is responsible for in-
creased IOP by obstruction of the aqueous humor out-
fl ow channel.
Patients with diabetes are at a moderate risk of de-
veloping POAG (about 5.5%)8,9. Th e lowest positive 
correlation for glaucoma development was determined 
in patients with systemic hypertension (3%)10,11, pa-
tients with migraine headaches and vasospasm and 
hypotension episodes.
Numerous studies have shown that there is a great-
er risk of developing glaucoma in patients with mod-
erate to high myopia. A study carried out in Sweden 
on more than 32,000 patients has confi rmed that myo-
pia is a signifi cant risk factor for glaucoma develop-
ment12. Increased axial length and lesser corneal thick-
ness in myopic patients results in decreased retinal 
microcirculation, which may contribute to glaucoma 
development.
Th e aims of this study were to detect POAG in its 
early stage in patients at a higher risk of its develop-
ment and to determine the risk group with the highest 
incidence of glaucoma.
Subjects and Methods
Th e study included four risk groups with 50 pa-
tients each, all of them aged over 40, and 50 patients as 
a control group. Group 1 included patients with diabe-
tes type 1 and type 2 with no proliferative diabetic 
retinopathy; group 2 included patients with arterial 
hypertension but with no retinal hemorrhage or ede-
ma, whereby hypertension was defi ned as systolic pres-
sure of 140 mm Hg or higher, and diastolic pressure of 
90 mm Hg or higher; group 3 included patients with a 
family history of POAG who had not been previously 
diagnosed and had not received any anti-glaucoma 
therapy; group 4 included patients with myopia be-
tween -3.0 and -8.0 diopters; and control group in-
cluded patients aged over 40 who did not belong to 
any risk group for developing POAG.
Th is research was conducted at Department of 
Ophthalmology, Osijek University Hospital Centre in 
Osijek. Th e patients included in the study were referred 
to general ophthalmology examination by their family 
physicians. Central visual acuity on both eyes was better 
than 0.3 with or without correction in all study patients.
Th e sample size of 140 patients was determined to 
be suffi  cient to estimate the prevalence of glaucoma 
with a 95% confi dence interval (95%CI), assuming the 
prevalence rate of 10%.
Exclusion criteria were as follows: patients who 
had already been diagnosed with glaucoma and IOP; 
and patients who had already received anti-glaucoma 
therapy.
Medical history was taken in all patients, followed 
by clinical examination and the following diagnostic 
procedures:
• central visual acuity was determined using Snel-
len optotypes;
• IOP was taken by the Goldmann applanation 
tonometer and gonioscopy with Goldmann 
three-mirror contact lens mounted on the Haag-
Streit biomicroscope;
• visual fi eld examination applying the Octopus 
perimetry program G1X on the Octopus perim-
eter 1-2-3 and FDT perimetry (Run threshold 
test C 20, Humphrey systems, Zeiss);
• central corneal thickness (CCT) measurement 
by ultrasound pachymetry using Echographe 
pachymeter, model Pocket II, Quantal medica; 
and
• photo of the optic nerve head was taken by the 
Zeiss FF 450 Plus fundus camera.
Pathologic fi ndings in at least two of these param-
eters (e.g., visual fi eld changes, excavation of optic disc 
with the cup/disc (C/D) ratio of 0.3 or greater, IOP of 
22 mm Hg or greater) meant that the patients were 
diagnosed with glaucoma.
Statistical analysis
Th e data obtained were systematized as variables of 
nominal type. Correlation between the results of diag-
nostic procedures and the patient category was tested 
by comparing p-values applying χ2-test and Fisher ex-
act test, depending on data. Th e signifi cance level was 
defi ned as α=0.05. Statistical analysis was done by SAS 
9.1 (SAS Institute Inc., Cary, NC, USA).
Results
Statistical analysis of the patients (applying χ2-test) 
in the risk groups based on the parameters defi ning 
glaucoma showed that distribution of patients with 
glaucoma was not equal in diff erent risk groups. Com-
parison of p-values showed that the  prevalence of 
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POAG in patients with a family history of primary sim-
plex glaucoma was statistically signifi cantly greater than 
in the groups of patients with diabetes and myopia, as 
well as in the control group. Th e diff erence was greatest 
in relation to the control group. Th ere was no statisti-
cally signifi cant diff erence in the prevalence of glauco-
ma between the groups of patients with a family history 
and patients with systemic hypertension (Fig. 1).
In patients with diabetes, the prevalence of POAG 
was 4%, which was not statistically signifi cant in relation 
to the control group (p=0.078 vs. defi ned signifi cance 
level of p<0.05). Th ese results are shown in Figure 2.
In patients with systemic hypertension, the POAG 
prevalence was 6%, which was statistically signifi cant 
in relation to the control group (p=0.04, which was less 
than the defi ned signifi cance level of p<0.05). Th ese 
results are shown in Figure 3.
In patients with a family history, the POAG preva-
lence was 14%, which was statistically more signifi cant 
than in the control group (p=0.0036 in comparison to 
defi ned signifi cance level of p<0.05), and also statisti-
cally more signifi cant than in the groups of patients with 
myopia and diabetes (p=0.04 in both groups, which was 
less than defi ned signifi cance level of p<0.05) (Fig. 4).
Fig. 1. Prevalence of primary 
open angle glaucoma 
in particular risk groups.
Fig. 2. Prevalence of primary open angle glaucoma 
in patients with diabetes.
Fig. 3. Prevalence of primary open angle glaucoma 
in patients with systemic hypertension.
Fig. 4. Prevalence of primary open angle glaucoma 
in patients with positive family history.
Fig. 5. Prevalence of primary open angle glaucoma 
in control group.
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Th e results of this research showed that, based on 
the set variables, not a single case of POAG was de-
tected in the control group (Fig. 5).
Discussion
Patients with diabetes are at a moderate risk of de-
veloping POAG. Th e possible pathogenetic sequence 
is disturbed microcirculation in the optic nerve head 
and changes of glial and neuronal activity, as well as in 
metabolism of the retina13, which can lead to apoptosis 
of retinal ganglion cells. Th us, diabetes may cause 
damage to neuronal metabolism and to retinal glia, 
which may further result in hypersensitivity of these 
cells to stress, as well as in the possible increase in IOP. 
Th is brings diabetes in direct positive correlation with 
development of glaucoma damage to the optic nerve.
In diabetic patients included in this research, the 
prevalence of POAG was 4%, which was not statisti-
cally signifi cant in relation to the control group 
(p=0.078 and p<0.05, respectively). Th ese results are 
similar to those obtained in the Framingham Eye 
Study14 and Baltimore Study15, according to which 
diabetes and POAG did not show signifi cant correla-
tion. Furthermore, the Collaborative Glaucoma Study 
also confi rmed that there was no signifi cant correla-
tion between diabetes and POAG16. However, in the 
Rotterdam Study, where the same parameters as in our 
study were used (visual fi eld damage, C/D ratio and 
IOP greater than 21 mm Hg), the prevalence of devel-
oping POAG in patients with diabetes was three times 
higher than in other studies17.
Numerous studies have confi rmed the signifi cance 
of vascular factors and hypertension for development 
of glaucoma. Th e Collaborative Normal Tension Glau-
coma Study showed that disc hemorrhage in patients 
with frequent migraine headaches and vasospasms was 
an important factor contributing to glaucoma progres-
sion18. Looped/coiled peripapillary blood vessels, peri-
papillary retinal nerve fi ber layer (RNFL) thinning, 
and arteriolar stenosis are the areas with greatest visual 
fi eld loss19. Th e Baltimore Study showed that increased 
systemic pressure may have a protective role only in 
the initial stage of glaucoma development, whereas in 
the later stage it stimulates glaucoma progression, 
mainly because it usually aff ects elderly people who 
already suff er from atherosclerosis, which directly dis-
turbs ocular perfusion pressure and blood fl ow auto-
regulation11. To preserve hemodynamic balance in the 
optic disc, it is necessary to maintain blood fl ow auto-
regulation, which means that whenever there is an in-
crease in IOP, peripheral vascular resistance decreases 
or the pressure in the ophthalmic artery increases20-22.
Despite the fact that some studies have shown pos-
itive correlation between IOP values and systemic 
blood pressure values, it was not confi rmed in a large 
population study (Baltimore Eye Survey). Some facts 
are contradictory. Namely, the same study confi rmed 
great and statistically signifi cant correlation between 
untreated systemic hypertension and glaucoma on the 
one hand, while on the other hand, the patients treated 
for hypertension included in the same study were not 
at a higher risk of developing glaucoma than the con-
trol group. It seems logical that increased systemic 
pressure damages capillary circulation and thus de-
creases optic disc perfusion, but from the physiological 
aspect these contradictory facts lead to the conclusion 
that systemic hypertension represents a low risk for 
development of glaucoma.
Positive family history of POAG correlates posi-
tively with more severe clinical symptoms of POAG, 
which is defi ned as increased vertical C/D ratio. How-
ever, in some studies, positive family history did not 
correlate with the degree of visual fi eld damage. Th us, 
in the study by Landers et al.23, it was concluded that 
positive family history of POAG did not have any in-
fl uence on the progression of glaucoma. Namely, they 
confi rmed that positive family history of POAG cor-
related with better results in visual fi eld test in patients 
under the age of 50, but not in older ones.
In the group of patients with a family history of 
POAG included in this study, 14% of patients were 
fi rst diagnosed with POAG, which was statistically 
more signifi cant than in the control group (p=0.0036 
and p<0.05, respectively), and also statistically more 
signifi cant than in the groups of patients with myopia 
and diabetes. Th is relatively high of prevalence POAG 
in the group with positive family history corresponds 
to the results obtained in other studies, where the 
prevalence is between 13% and 25%24,25.
Th is high percentage leads to the conclusion that 
positive family history represents the greatest risk fac-
tor for development of glaucoma compared to other 
factors analyzed in all risk groups. It is well known that 
in one-sixth of all glaucoma cases, there is a positive 
family history. Th e risk of glaucoma development is 
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almost 10 times higher in fi rst-degree relatives than in 
control groups26. Also, some studies confi rmed that the 
fi rst-degree relatives of patients with POAG had a 
42.5% higher risk of increased IOP than patients in 
the control group, increased C/D ratio was 62.2% in 
comparison to 16.6% in the control group, and the risk 
of glaucoma development was 22.0% in comparison to 
2.3% in the control group26. Th is positive correlation 
between family history and POAG development may 
be explained by the fact that two of the variables taken 
into account for diagnosing glaucoma (IOP and C/D 
ratio) are genetically determined27.
Even though the mechanisms regarding myopia 
and glaucoma development are still insuffi  ciently ex-
plained, it is assumed that the optic nerve head in 
myopic eyes is structurally more sensitive to glaucoma 
damage due to structural changes in connective tis-
sue28,29. Some studies show that the risk of developing 
glaucoma is proportional to myopia degree. According 
to Mitchell et al. in the Blue Mountains Eye Study, the 
odds ratio for glaucoma development was 2.3 in low 
myopia and 3.3 in moderate to high myopia30. Th e 
prevalence of POAG in patients with myopia in our 
study was 4%, which was not statistically signifi cant in 
relation to the control group (p=0.0782 and p<0.05, 
respectively). Daubs and Crick also confi rmed greater 
prevalence of POAG in patients with myopia31.
Conclusion
Early diagnosis of glaucoma is primarily based on 
morphological analysis of the optic nerve head, IOP 
and CCT measurement, as well as on the analysis of 
visual fi eld  progression applying up-to-date functional 
tests. Histologic studies have confi rmed that signifi -
cant loss of RNFL and optic nerve fi bers occurs prior 
to functional vision fi eld losses measurable by current 
diagnostics. Unfortunately, technology that could de-
tect the disease in its initial stages does not exist. One 
of the reasons is certainly the fact that the etiopathol-
ogy of the disease has not yet been completely ex-
plained. Th is study confi rmed the signifi cance of doing 
early screening in risk groups of patients in order to 
detect glaucoma as early as possible. Only early diag-
nosis and timely treatment can prevent development 
of permanent complications that will result in blind-
ness.
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Sažetak
UČESTALOST GLAUKOMA OTVORENOG KUTA U RIZIČNIM SKUPINAMA 
U OSJEČKO-BARANJSKOJ ŽUPANIJI
J. Barać, D. Biuk, S. Matić, I. Barać, G. Pelčić i M. Bradvica
Cilj ove prospektivne studije bio je dijagnosticirati primarni glaukom otvorenog kuta (POAG) u ranom stadiju kod 
 bolesnika s visokim rizikom od razvoja POAG te identifi cirati skupinu bolesnika s najvećom učestalošću POAG. Studija je 
provedena na Zavodu za oftalmologiju Kliničkog bolničkog centra Osijek i uključila je 250 bolesnika podijeljenih u pet 
skupina: skupina 1: bolesnici s dijabetes melitusom tip 1 i 2; skupina 2: bolesnici s arterijskom hipertenzijom (krvni tlak 
>140/90 mm Hg); skupina 3: bolesnici s pozitivnom obiteljskom anamnezom POAG; skupina 4: bolesnici s miopijom izme-
đu -3 i -8 dioptrije sfere; skupina 5: kontrolna skupina koja uključuje bolesnike starije od 40 godina i bez rizičnih čimbenika 
za razvoj POAG. Rezultati studije pokazuju da distribucija bolesnika s glaukomom nije jednaka u svim skupinama. Učesta-
lost POAG u svih bolesnika bila je 5,6%, dok je u bolesnika s pozitivnom obiteljskom anamnezom bila 14%, što je statistički 
zančajno više nego u bolesnika s dijabetesom i miopijom (4%) i u kontrolnoj skupini. Razlika je bila najveća u usporedbi s 
kontrolnom skupinom. Nije pronađena statistički značajna razlika u učestalosti POAG između bolesnika s pozitivnom obi-
teljskom anamnezom (14%) i bolesnika s arterijskom hipertenzijom (6%). Dobiveni rezultati navode na zaključak da je za 
pojavu POAG od svih analiziranih rizičnih čimbenika najvažnija pozitivna obiteljska anamneza.
Ključne riječi: Prospektivna istraživanja; Glaukom otvorenog kuta; Hipertenzija; Miopija; Glaukom; Rizični čimbenici; 
 Kontrolne skupine
